DUBLIN--(BUSINESS WIRE)--The "The US Lymphedema Market: Size, Trends & Forecasts (2019-2023 Edition)" report has been added to ResearchAndMarkets.com's offering.
US Lymphedema Market: Size, Trends & Forecasts (2019-2023 Edition), provides analysis of the US lymphedema market, with detailed analysis of market size and growth, number of patients and penetration, number of patients diagnosed, patients by causes and demographics, etc. The report also provides the detailed analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by average selling price, etc.
The US Lymphedema market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2019-2023). The market is expected to be driven by various growth-enhancing factors such as growing prevalence of breast cancer, increasing obesity, rise in urban population, escalating healthcare expenditure, rising prevalence of arthritis, and surge in disposable income.
However, the market is not free from challenges that are hindering its growth. Some of the major challenges faced by the market are high cost involved, improvement in cancer treatment, and lack of awareness.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2019-2023, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
The major players dominating the US Lymphedema market are Tactile Systems Technology Inc., Bio Compression System, Lympha Press (Mego Afek) and Essity (BSN Medical). The four companies have been profiled in the report providing a detailed analysis of their financial information and business strategies.
Key Topics Covered:
1. Executive Summary
2.1 Lymphedema: An Overview
2.2 Types of Lymphedema
2.3 Treatment of Lymphedema
3. Market Analysis
3.1 The US Lymphedema Market: An Analysis
3.1.1 The US Lymphedema Market by Number of Patients
3.1.2 The US Lymphedema Market by Number of Patients Diagnosed
3.1.3 The US Lymphedema Market by Number of Diagnosed Patients Severity
3.1.4 The US Lymphedema Total Addressable Market (TAM)
3.2 The US Lymphedema Market: Patient Analysis
3.2.1 The US Lymphedema Patients by Causes (Cancer, CVI, Surgery, Trauma, Primary lymphedema, and Others)
3.2.2 The US Lymphedema Patients by Demographics (Gender (Male, Female), Age Group (0-18 Years, 19-44 Years, 45-64 Years, 65+ Years))
3.3 The US Lymphedema Pneumatic Compression Device (PCD) Market: An Analysis
3.3.1 The US Pneumatic Compression Device (PCD) Market by Case Adoption
3.3.2 The US Pneumatic Compression Device (PCD) Market by Average Selling Price (ASP)
3.3.3 The US Pneumatic Compression Device (PCD) Market by Value
3.4 The US Lymphedema Market: New Product Analysis
3.4.1 The US Lymphedema Market New Product: Ubenimex
3.4.2 The US Lymphedema Market New Product: Lymfactin
4. Market Dynamics
4.1 Growth Driver
4.1.1 Growing Prevalence of Breast Cancer
4.1.2 Increasing Obesity
4.1.3 Rise in Urban Population
4.1.4 Escalating Healthcare Expenditure
4.1.5 Rising Prevalence of Arthritis
4.1.6 Surge in the Disposable Income
4.2.1 High Cost Involved
4.2.2 Improvement in Cancer Treatment
4.2.3 Lack of Awareness
4.3 Market Trends
4.3.1 Advancement in Treatment Options
4.3.2 Growing Popularity of Pneumatic Compression Devices
5. Competitive Landscape
5.1 The US PCD Players by Market Share
5.2 The US PCD Market Players Comparison
6. Company Profiles
- Bio Compression System
- Essity (BSN Medical)
- Lympha Press (Mego Afek)
- Tactile Systems Technology Inc.
For more information about this report visit https://www.researchandmarkets.com/r/j9hdz